The takeover battle is getting uglier all the time. Warner-Lambert is revealing confidential details of its Lipitor deal with Pfizer . What it showed is how much Pfizer stands to gain from Lipitor, a blockbuster drug that treats cholesterol. Warner Lambert even went as far as issuing a veiled threat that it would terminate its sales and marketing agreement with Pfizer if Pfizer didn't abandon its efforts to acquire Warner Lambert. Meanwhile, Pfizer is taking its offer to the Street.
Readers debate the merits of the city by the Bay.
Plus, some Austin residents tell America to stay out of their town, in letters to the editor . Click here to sign up for the free e-mail. Time Inc. New Media.